Alpha-glucosidase inhibitors

cis-Tiliroside
Catalog No: CFN92265

Kaempferol-3-O-β-D-(6''-O-coumaryl) glycoside has antioxidant activity and α-glucosidase inhibitory effects, it could potentially be used for food additives and the development of useful natural compounds.

Chrysin 6-C-arabinoside 8-C-glucoside
Catalog No: CFN92284

Chrysin-6-C-arabinosyl-8-C-glucoside and chrysin-6-C-glucosyl-8-C-arabinoside are α-glucosidase inhibitors, α-glucosidase inhibitors are widely used in the treatment of type 2 diabetes.

Chrysin 6-C-glucoside 8-C-arabinoside
Catalog No: CFN92285

Chrysin-6-C-arabinosyl-8-C-glucoside and chrysin-6-C-glucosyl-8-C-arabinoside are α-glucosidase inhibitors, α-glucosidase inhibitors are widely used in the treatment of type 2 diabetes.

Chebulic acid
Catalog No: CFN92293

Chebulic acid has effects against the progression of AGE-induced endothelial cell dysfunction, may constitute a promising intervention agent against diabetic vascular complications; it at both doses (25 and 50 mg/kg) improves biochemical alterations caused by renal ischemia in diabetic rats. Chebulic acid significantly reduced the tert-butyl hydroperoxide (t-BHP)-induced cell cytotoxicity, intracellular reactive oxygen species level, and the ratio of GSSH, oxidized form of glutathione (GSH) to the over total GSH (GSH + GSSG) (4.42%) as compared to that with t-BHP alone (8.33%).

Chikusetsusaponin IV
Catalog No: CFN90542

Chikusetsusaponin IV may relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.